Funds and ETFs Procter & Gamble Health Limited

Equities

PGHL

INE199A01012

Pharmaceuticals

Delayed Bombay S.E. 05:35:04 2024-04-24 am EDT 5-day change 1st Jan Change
4,739 INR +0.59% Intraday chart for Procter & Gamble Health Limited +0.98% -4.19%

ETFs positioned on Procter & Gamble Health Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.00% 117 M€ +0.83% -
0.00% 34 M€ +2.14% -
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company is engaged in the manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company’s brands include Cosome, Evion, Neurobion, Seven Seas, Nasivion, Polybion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Evion range has different variants with different levels of Vitamin E, such as Evion 400, Evion 200, and Evion 600. Neurobion offers a range of neurotropic B-Vitamins which are a combination to help treat nerve damage and regenerate the nerves to relieve symptoms. Nasivion Classic Nasal Spray starts working on a blocked nose in 25 seconds. Polybion is a brand that helps with release and hence supports an active life.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PGHL Stock
  4. Funds and ETFs Procter & Gamble Health Limited